Free Trial
OTCMKTS:HLUYY

H. Lundbeck A/S (HLUYY) Stock Price, News & Analysis

H. Lundbeck A/S logo
$22.00 -0.01 (-0.02%)
As of 08/9/2022

About H. Lundbeck A/S Stock (OTCMKTS:HLUYY)

Key Stats

Today's Range
$22.00
$24.00
50-Day Range
$22.00
$22.00
52-Week Range
$10.00
$31.55
Volume
7,500 shs
Average Volume
1,758 shs
Market Capitalization
$21.91 billion
P/E Ratio
25.00
Dividend Yield
0.91%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HLUYY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for H. Lundbeck A/S and its competitors with MarketBeat's FREE daily newsletter.

HLUYY Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
H Lundbeck AS (LUNAM)
H. Lundbeck A/S (HLBBF)
Denmark's H. Lundbeck To Buy Longboard Pharmaceuticals For $60/share Cash
See More Headlines

HLUYY Stock Analysis - Frequently Asked Questions

H. Lundbeck A/S's stock was trading at $22.00 at the beginning of the year. Since then, HLUYY shares have increased by 0.0% and is now trading at $22.00.

H. Lundbeck A/S (OTCMKTS:HLUYY) issued its quarterly earnings results on Wednesday, November, 4th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.01 by $0.16. The business had revenue of $547.05 million for the quarter, compared to the consensus estimate of $514.82 million. H. Lundbeck A/S had a trailing twelve-month return on equity of 13.74% and a net margin of 6.74%.

The following companies are subsidiaries of H. Lundbeck A/S: Alder BioPharmaceuticals, and Prexton Therapeutics.

Shares of HLUYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/04/2015
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Private Households
Sub-Industry
N/A
Current Symbol
OTCMKTS:HLUYY
CIK
N/A
Employees
5,348
Year Founded
1915

Profitability

EPS (Trailing Twelve Months)
$0.88
Trailing P/E Ratio
25.00
Forward P/E Ratio
10.48
P/E Growth
N/A
Net Income
$209.69 million
Net Margins
6.74%
Pretax Margin
7.83%
Return on Equity
13.74%
Return on Assets
7.16%

Debt

Debt-to-Equity Ratio
0.32
Current Ratio
1.15
Quick Ratio
0.71

Sales & Book Value

Annual Sales
$2.59 billion
Price / Sales
8.45
Cash Flow
$3.36 per share
Price / Cash Flow
6.54
Book Value
$14.60 per share
Price / Book
1.51

Miscellaneous

Outstanding Shares
995,741,000
Free Float
N/A
Market Cap
$21.91 billion
Optionable
Not Optionable
Beta
0.68

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:HLUYY) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners